.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
US Army
Novartis
Express Scripts
UBS
Colorcon
AstraZeneca
Covington
Daiichi Sankyo
Mallinckrodt

Generated: June 25, 2017

DrugPatentWatch Database Preview

Memantine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for memantine hydrochloride and what is the scope of memantine hydrochloride patent protection?

Memantine hydrochloride
is the generic ingredient in three branded drugs marketed by Sun Pharma Global, Unichem Labs Ltd, Amneal Pharms, Forest Labs Llc, Mylan Pharms Inc, Lupin Ltd, Ajanta Pharma Ltd, Silarx Pharms Inc, Apotex Inc, Macleods Pharms Ltd, Upsher-smith Labs, Orchid Hlthcare, Bio-pharm Inc, Dr Reddys Labs Ltd, Strides Pharma, Teva Pharms, Puracap Pharm Llc, Torrent Pharms Ltd, Wockhardt Ltd, Aurobindo Pharma Ltd, Anchen Pharms, Jubilant Generics, and Alembic Pharms Ltd, and is included in thirty-one NDAs. There are eight patents protecting this compound and five Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for memantine hydrochloride. Thirty-seven suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: memantine hydrochloride

Tradenames:3
Patents:8
Applicants:23
NDAs:31
Drug Master File Entries: see list28
Suppliers / Packagers: see list37
Bulk Api Vendors: see list69
Clinical Trials: see list2,412
Patent Applications: see list1,926
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:memantine hydrochloride at DailyMed

Pharmacology for Ingredient: memantine hydrochloride

Tentative approvals for MEMANTINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe5MGTABLET; ORAL
► Subscribe► Subscribe10MGTABLET; ORAL
► Subscribe► Subscribe10MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
TABLET;ORAL203175-002Oct 13, 2015ABRXNoNo► Subscribe► Subscribe
Silarx Pharms Inc
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
TABLET;ORAL207236-002Nov 10, 2016ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL206028-001Sep 28, 2016ABRXNoNo► Subscribe► Subscribe
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-001Jun 21, 2010ABRXYesNo8,362,085*PED► SubscribeY► Subscribe
Upsher-smith Labs
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
TABLET;ORAL090043-002Jul 31, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: memantine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-001Jun 21, 20105,061,703*PED► Subscribe
Forest Labs Llc
NAMENDA
memantine hydrochloride
TABLET;ORAL021487-002Oct 16, 20035,061,703*PED► Subscribe
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-002Jun 21, 20105,061,703*PED► Subscribe
Forest Labs Llc
NAMENDA
memantine hydrochloride
TABLET;ORAL021487-002Oct 16, 20035,614,560► Subscribe
Forest Labs Llc
NAMENDA
memantine hydrochloride
TABLET;ORAL021487-001Oct 16, 20035,061,703*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Johnson and Johnson
McKinsey
Accenture
Covington
UBS
Teva
Cerilliant
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot